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Abstract Microarray technology allows us to perform
high-throughput screening of changes in gene expression.
The outcome of microarray experiments largely depends
on the applied analysis methods and cut-off values chosen.
Results are often required to be veriﬁed using a more
sensitive detection technique, such as quantitative real-time
PCR (qPCR or RT-PCR). Throughout the years, this
technique has become a de facto golden standard. Indi-
vidual qPCRs are time-consuming, but the technology to
perform high-throughput qPCR reactions has become
available through PCR-arrays that allow up to 384 PCR
reactions simultaneously. Our current aim was to investi-
gate the usability of a RT
2 Proﬁler
TM PCR-array as
validation in a nutritional intervention study, where the
measured changes in gene expression were low. For some
differentially expressed genes, the PCR-array conﬁrmed
the microarray prediction, though not for all. Furthermore,
the PCR-array allowed picking up the expression of genes
that were not measurable on the microarray platform but
also vice versa. We conclude that both techniques have
their own (dis)advantages and speciﬁcities, and for less
pronounced changes using both technologies may be useful
as complementation rather than validation.
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Introduction
Gene expression microarrays have become the leading
technology to evaluate changes in genome wide gene
expression under different conditions. To conﬁrm results
from microarray studies, a selection of differentially
expressed genes of interest is generally veriﬁed using a
highly sensitive technique, mostly a quantitative real-time
reverse transcriptase PCR (RT-PCR/qPCR) reaction [8,
21]. Even though qPCR is considered to be a ‘‘golden
standard’’ or a necessary validation [11, 15, 16, 19, 20], it
has also been stated that qPCR results are not always better
[2] or validation is not always necessary [21]. In a qPCR
reaction, cDNA is synthesised from mRNA molecules
present in the sample, which is then ampliﬁed exponen-
tially using a combination of gene-speciﬁc primers,
labelled nucleotides and the DNA polymerase enzyme,
theoretically doubling the amount of cDNA at every cycle.
Upon analysis, the expression level of the target gene is
computed relative to the expression level of one or more
reference genes, often housekeeping genes. Selecting
proper housekeeping genes is one of the most critical
aspects of the analysis, since they need to be constantly
expressed between all samples and conditions in the
experiment. A survey of publications reveals a wide range
in correlations between microarray and qPCR results [3–7,
12, 19].
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DOI 10.1007/s12263-008-0094-1To allow qPCR in a more high-throughput way, several
companies have developed a practical solution to perform
up to 384 qPCR reactions on one single plate, such as the
TaqMan
TM Gene Expression Arrays from Applied Bio-
systems and RT
2 Proﬁler
TM PCR Array System from
SABiosciences. PCR-arrays have mainly been used in
cancer research, but also in some other ﬁelds, for example,
drug metabolism [13]. At the time of writing, 74 RT
2
Proﬁler
TM PCR-arrays are catalogued that contain primer
sequences for genes belonging to a speciﬁc function,
structure or pathway (e.g., apoptosis, common cytokines,
NF-jB signalling pathway) or disease (e.g., cancer). In
addition, arrays can be custom-made. For the 96-well
system, every plate contains ﬁve housekeeping genes
(B2M, HPRT1, RPL13a, GADPH and ACTB), three
positive PCR controls, three reverse transcriptase controls
and one control to detect the presence of genomic cDNA
contamination. Correlations between results of several RT
2
Proﬁler PCR-arrays and qPCR have been reported to be
good [3, 13].
In human nutritional intervention studies, the response
of a given diet on gene expression can be minimal. Most
publications in this ﬁeld make use of qPCR to validate a
few genes of interest [14, 18], but no larger scale approa-
ches have been used. The goal of this study is to evaluate if
for this purpose a PCR-array can be used in a dietary
intervention study where the expected changes are small.
Materials and methods
This paper elaborates on a study investigating the rela-
tionship between diet and inﬂammation [10]. For
microarray analysis, mRNAs from peripheral mononuclear
blood cell (PBMC) samples of eight obese subjects were
collected. These subjects participated in both the ﬁsh oil
(FishOil) and weight loss (WeightLoss) interventions.
More details about the study design are provided in the
original paper [10].
RNA was pooled with the control (Cy3) being the
control diet and with either the WeightLoss or FishOil end-
point as Cy5. RNA quantity and purity were determined
using the NanoDrop ND-2000 (Nanodrop Technologies,
Wilmington, DE, USA), and RNA integrity was assessed
by determining the RNA 28S/18S ratio using the Bioana-
lyzer 2100 (Agilent Technologies, Santa Clara, CA, USA).
Pooled RNA samples were hybridised to Agilent Human
1A G4110B microarrays, containing 22,575 reporters. This
was done according to a dye-ﬂip design, resulting in a total
number of four arrays. Array quality control was performed
in Spotﬁre DecisionSite 9.0 and R 2.5.1 using the limma
library version 2.10.5 [17]. Reporters passed quality con-
trol when (1) signals of both channels consisted of more
than 55 pixels; (2) both signals were higher than 2.6 times
the standard deviation of the local background and (3) at
least one signal was not saturated. All further data analyses
were performed in R. Within-array normalisation was
performed by using the LOESS algorithm. Next, a linear
model was ﬁtted for every reporter and a moderated t test
was performed. To ensure microarray reporter speciﬁcity,
all reporters were reannotated using stable UniProt and
EnsEMBL identiﬁers [9].
Microarray results were validated using a speciﬁc PCR-
array (SABiosciences, Frederick, USA) that met two cri-
teria. We selected all human PCR-arrays that contained a
relatively large number of genes that were differentially
expressed (P value\0.05 and |FC|[1.2) by the two
treatment comparisons performed in the microarray study
and that contained a gene set that was related to the
observed changes in plasma metabolic parameters. Based
on the outcome, the 96-well plate Human Common Cyto-
kines PCR-array (PAHS-021) was selected.
The mRNA of each individual was converted into
cDNA using the RT
2 First Strand Kit (SABiosciences,
Frederick, USA). This cDNA was then added to the RT
2
SYBR Green qPCR Master Mix (SABiosciences, Freder-
ick, USA). Next, each sample was aliquotted on 24 Human
Common Cytokine PCR-arrays. All steps were done
according to the manufacturer’s protocol for the ABI
Prism 7000 Sequence Detection System. RNA quality was
good, with 260/280 ratios slightly higher than 2.0 and
260/230 ratios slightly higher than 1.8. To analyze the
PCR-array data, an MS-Excel sheet with macros was
downloaded from the manufacturer’s website (http://www.
sabiosciences.com/pcrarraydataanalysis.php). The website
also allowed online analysis. We preferred to use ofﬂine
calculations since it was not possible to save the results
online, and even more importantly because it was easier to
track the formulas and to understand what was being done.
For each PCR reaction, the Excel sheet calculated two
normalised average Ct values, a paired t test P value and a
fold change. To ﬁlter out undetectable genes, an extra
quality check was added by us: for each intervention, the
PCR gene product was ﬂagged as either ‘‘good’’ or ‘‘bad’’.
A gene was considered good when in both the control and
the dietary intervention the difference between the mea-
sured genomic cDNA Ct value (maximum 35) and the
measured Ct value of the gene was at least three cycles in
the same ﬁve out of eight subjects for each comparison. For
each included gene, individual measurements that were not
detected were excluded from further analysis. This was
done to correct the lack of robustness of the analysis
spreadsheet, as provided by the manufacturer, and to take
into consideration the outlying values that have a consid-
erable inﬂuence on the calculated fold change and its
associated P value. Data normalisation was based on
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123correcting all Ct values for the average Ct values of several
constantly expressed housekeeping genes (HKGs) present
on the array. PCR-array analysis results were evaluated and
also compared to the outcome of the gene expression
microarrays.
Results and discussion
In our current analysis, only four HKGs (HPRT1, RPL13A,
GAPDH and ACTB) were used for normalisation. Beta-2-
microglobulin (B2M) was not included, since it was signif-
icantlyalteredonthePCR-arrayaftertheweightlossperiod.
Applying the ﬂagging criteria resulted in ﬁnding 29 and 33
detectable genes after the FishOil and the WeightLoss
intervention, respectively. All detected genes in the FishOil
intervention were also measured accurately in the Weight-
Loss comparison. The ﬂagging procedure removed several
observations that were most likely caused by failing ampli-
ﬁcations, since only one value of one subject was
undetectable(Ct[35).Notehoweverthatinsomecasesthis
ﬂagging may be somewhat conservative: for example, for
two subjects in the FishOil experiment, the IFNK gene
changed from baseline undetected (Ct = 35) to Ct values of
30.27 and 30.72 cycles. All other subjects had a nearly
constant Ctvalue ranging between29.5and 29.8 cycles. The
samepatternoccurredfortwosubjects,andthereforeitcould
wellbearealbiologicaleffect.Ingeneral,themeasurements
obtainedbythe PCR-array wereconsistent betweensubjects
and show very small variation, as in regular qPCR.
Table 1 summarizes our ﬁndings with respect to the
detectable genes on the PCR-array and their corresponding
microarray values. The coverage of the detected PCR genes
on the reannotated microarray was 100%. Seven PCR
genes were present more than once on the Agilent micro-
array platform. For two of those genes (FASLG and TNF)
their corresponding reporters on the microarray were
identical, speciﬁc, and showed only a slight difference in
fold change. The other ﬁve genes (ACTB, CSF1, PDGFA,
TFGA and TFGB1) had two different microarray reporter
sequences that align to different parts of the gene product.
For these seven genes, the fold change for the highest
expressed reporter was chosen to represent the gene on the
microarray. It was not possible to measure the expression
of ﬁve of the PCR-measured genes on the microarray: two
genes (B2M, TNFSF14) were always saturated, whereas
the other three (BMP8B, CSF1, IFNK) were ﬁltered out
during microarray quality control due to a too low back-
ground-corrected intensity value. All other genes on the
PCR-array, apart from IFNA1, were also present on the
reannotated microarray, where IFNA4 was only covered by
reporters targeting several of its family members as well.
Within the complete list of genes (cf. Supplementary
Table 1), only *10% of genes detected on the PCR-array
could not be detected on the microarray. Conversely,
*50% of genes, for which primers were available on the
PCR-arrays, could be detected on the microarray but not on
the PCR-array. This result contradicts the original
hypothesis of a better sensitivity of qPCR in comparison to
microarray [1, 19]. This could be explained by the different
criteria used and may point to the fact that a required
threefold difference in Ct value compared to the genomic
control, as suggested by the manufacturer, is too strict.
However, this cannot offer an explanation for all the
ﬁndings, illustrated by the INHA gene, which was detect-
able on the microarray in low concentrations and
signiﬁcant for all comparisons, but had Ct values of *35
on the PCR-array. On the other hand, with highly expres-
sed genes, the microarray measurements were sometimes
saturated. This saturation did not occur on the qPCR. Thus,
the reported lower dynamic range of microarray measure-
ments [1, 19] was conﬁrmed for this end of the spectrum.
In principle, a simple rescanning of the array at a lower
scanning intensity could overcome this problem. However,
such rescanning procedures have to be done shortly after
hybridisation, and in our experience, in practice, this is not
often done. We did not observe that array performance
would be especially lower with lower expression levels or
fold changes, as reported before [1, 5–7, 15, 19], though
several authors also found acceptable detection levels of
lower fold changes or expression levels or less correlation
between expression and accuracy [6, 19, 20]. In our study,
consistency in direction of change between both methods
remained high down to the 10% change range for the
qPCR. Finally, even though a trend of the microarray in
estimating smaller fold changes as compared to qPCR was
observed [6, 22], the difference was quite limited.
With respect to signiﬁcantly regulated genes, some
changes were consistent while few were not (cf. Table 1
and Supplementary Table 1). The P values of the PCR-
array were much higher than the P values of the micro-
array. However, the microarray material was pooled,
whereas the PCR samples were not, resulting in much
lower variation for the ﬁrst analysis technique. Since this
would logically lead to lower P values, this effect was not
taken into account for the comparison. The majority of
genes on both the PCR-array and the microarray were not
differentially expressed for either technology. Among dif-
ferentially expressed genes the PDFGA gene was detected
as signiﬁcant under both experimental conditions on the
microarray and its computed fold changes were conﬁrmed
on the PCR-array. For TNFSF4, the results also corre-
sponded: for both platforms downregulated for WeightLoss
and ﬂagged for FishOil. TNFSF8 showed slight downreg-
ulation for FishOil but no change for WeightLoss. Other
genes were less concordant with IL24 as most conﬂicting
Genes Nutr (2008) 3:153–157 155
123gene, showing opposite values for both comparisons. Bad
annotation or crosshybridisation are unlikely causes for this
inconsistency, since both arrays were very carefully
annotated in our study, as the microarray contains speciﬁc
probes for this gene, and the PCR primers were designed to
be speciﬁc for all gene variants. It may however be
explained by a possible difference in splice variants
detected by the two technologies, as IL24 has more than
one associated transcript. It is known that between-plat-
form consistency decreases with different primers [5, 6, 19]
or increased distance on the sequence between them [7].
Unfortunately, since the primer sequences of the PCR
products are not publicly available, we cannot verify this
possible cause of discrepancy.
In conclusion, we have observed consistencies and dif-
ferences between results obtained by two different
technologies. In general, we could not observe a better
detection level of the PCR-array, though this may be
caused by the chosen quality criteria set. Especially with
different probes/primers, it is hard to decide which tech-
nology gives a more accurate measurement. Different
results may be considered complementary instead of con-
tradictory. Especially, for nutritional studies, where effects
can be expected to be small, one could argue that running a
microarray with a broader coverage could be followed by
using a PCR-array focused at a speciﬁc process, to possibly
detect extra transcripts. However, current and future costs
will also play a role in the choice of the platforms to be
Table 1 Detectable reporters
on RT
2 Proﬁler
TM PCR-array in
human PBMCs
Calculated fold changes of 34
detectable PCR gene products
as compared to the fold changes
derived from the microarray
experiment for each
intervention
FC fold change, MA microarray,
N/A not available, PCR PCR-
array
* P\0.05
Gene Number of reporters on MA FishOil versus Control WeightLoss versus Control
FC–MA FC–PCR FC–MA FC–PCR
ACTB 2 1.01 -1.05 1.03 -1.06
B2M 1 N/A -1.09 N/A 21.23*
BMP6 1 -1.02 -1.39 -1.17* -1.15
BMP8B 1 N/A -1.42 N/A 1.11
CSF1 4 1.11 1.04 -1.05 -1.15
FASLG 2 -1.01 -1.11 -1.04 -1.04
GAPDH 1 -1.01 -1.08 -1.07 -1.06
GDF11 1 -1.02 -1.09 -1.07 1.05
HPRT1 1 -1.00 -1.11 -1.11* -1.05
IFNG 1 -1.03 -1.06 -1.21* -1.07
IFNK 1 N/A N/A N/A -1.38
IL15 1 -1.03 -1.21 -1.08 -1.05
IL16 1 1.03 -1.07 -1.13* -1.08
IL18 1 -1.10 -1.13 1.02 -1.07
IL1B 1 1.05 -1.06 1.03 1.02
IL24 1 1.20* -1.14 -1.29* 1.05
IL7 1 N/A N/A -1.19* -1.43
LTA 1 1.01 1.05 -1.09* -1.09
LTB 1 1.00 -1.05 -1.06* -1.12
PDGFA 2 -1.10* -1.24 -1.36* -1.46
RPL13A 1 1.02 -1.01 -1.05 -1.08
TGFA 2 -1.03 1.03 -1.15* -1.07
TGFB1 2 1.07 -1.03 -1.01 1.02
TGFB3 1 N/A N/A 1.06 1.32
TNF 2 1.09* -1.10 -1.07 -1.12
TNFSF10 1 -1.07* -1.14 1.10* -1.18
TNFSF12 1 1.03 -1.06 -1.03 1.03
TNFSF13 1 -1.02 -1.03 1.00 -1.01
TNFSF13B 1 -1.08 -1.23 -1.00 -1.03
TNFSF14 1 N/A -1.33 N/A 1.02
TNFSF4 1 N/A N/A -1.28* -1.48
TNFSF8 1 -1.08* -1.25 1.01 1.02
TXLNA 1 -1.13* 1.08 1.07* -1.06
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123utilized. Finally, we conclude that PCR-arrays should not
be considered a perfect validation tool, since both array
technologies have their own speciﬁc detection limits and
neither can be considered to be the real golden standard.
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